Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

6% growth for Japanese Rx market last fiscal year

This article was originally published in Scrip

Executive Summary

Japan's total prescription drug market grew by 5.5% to ¥9,534.9 billion ($120 billion) in the 12 months to 31 March, the fiscal year for most firms in the country and ahead of the 1 April general reimbursement price cut that is set to dampen growth this year.



Related Companies